Appoints Daniel Faga as Class I director effective Nov 26, 2021

ANAPTYSBIO, INC

Daniel Faga appointed to board as Class I director, effective immediately on Nov 26, 2021.
Received option for 2,321 shares at closing price on appointment date, vesting fully on Feb 10, 2022.
Also granted option for 11,000 shares at same exercise price, vesting monthly over three years.
Company entered into standard indemnification agreement with Faga.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Daniel Faga

Class I Director

ANAB · ANAPTYSBIO, INC

Effective: 2021-11-26
Filed: November 29, 2021, 6:59 PM ET

On November 26, 2021, AnaptysBio, Inc. (the “Company”) appointed Mr. Daniel Faga, as a Class I director on its board of directors (the “Board”), effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Daniel Faga was appointed as Class I Director at ANAPTYSBIO, INC.

Action: appointed
Role: Class I Director

Exact text from the filing

On November 26, 2021, AnaptysBio, Inc. (the “Company”) appointed Mr. Daniel Faga, as a Class I director on its board of directors (the “Board”), effective immediately.

View on SEC.gov

ANAPTYSBIO, INC filing history →

Source: SEC EDGAR

accession 0001370053-21-000075

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.